- Home
- SBET vs EWTX Comparison
SBET vs EWTX Comparison
Compare SBET & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBET | EWTX |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SBET | EWTX |
|---|---|---|
| Price | $10.91 | $24.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $31.00 | ★ $35.89 |
| AVG Volume (30 Days) | ★ 10.1M | 1.2M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,106,030.00 | N/A |
| Revenue This Year | $78,838.41 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 239.01 | N/A |
| 52 Week Low | $2.26 | $10.60 |
| 52 Week High | $124.12 | $35.50 |
Technical Indicators
Market Signals| Indicator | SBET | EWTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 64.10 |
| Support Level | $9.38 | $23.13 |
| Resistance Level | $12.29 | $24.66 |
| Average True Range (ATR) | 0.69 | 1.32 |
| MACD | 0.31 | -0.26 |
| Stochastic Oscillator | 52.06 | 52.51 |
Price Performance
Historical ComparisonAbout SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.